The additive manufacturing (AM) revolution is in full swing. The global market for medical applications alone is expected to grow from $355 million in 2012 to almost $1 billion by 2019. The use of AM, or 3-D printing, has been widespread across a number of sectors for the last few years for prototyping and modeling, but real-world commercial opportunities are now beginning to come to the fore as research and development projects identify new uses and techniques.
One such project is A-FOOTPRINT, a joint research and innovation initiative led by Glasgow Caledonian University and headed up by Professor Jim Woodburn. The objective is to develop cost-effective orthoses – bespoke inserts or footbeds that are fitted into shoes - for common disabling conditions with very short turnaround times from appointment to delivery.
In this exclusive interview, Prof Woodburn discusses the findings from the A-FOOTPRINT project so far and how these can be applied to this rapidly developing market.
RECOMMENDED
Digital Transformation in Pharma: Navigating CMO Partnerships and Supply Chain Resilience
2025-01-22
Sustainability and Inclusivity in Pharma Manufacturing: Insights from AstraZeneca’s People Hub
2024-12-11
Upcoming Events
GenAI Life Science & Health 2025
September 01 - 03, 2025
Berlin, Germany
Register Now |
View Agenda |
Learn More
DigIT Pharma AI Commercial Excellence & Health 2025
September 01 - 03, 2025
Palace Hotel Berlin, Germany
Register Now |
View Agenda |
Learn More
AI for Pharma & Healthcare
23 - 25 September, 2025
Amsterdam
Register Now |
View Agenda |
Learn More